Exact Mass: 294.0753

Exact Mass Matches: 294.0753

Found 105 metabolites which its exact mass value is equals to given mass value 294.0753, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Estazolam

12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene

C16H11ClN4 (294.0672)

Estazolam is only found in individuals that have used or taken this drug. It is a benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABA_A) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

TRAM-3

(2-Chlorophenyl)diphenylmethanol

C19H15ClO (294.0811)

(3S,4R)-3,4,5-trihydroxy-8-oxospiro[6,7-dihydronaphthalene-5,2-oxolane]-2-carboxylic acid

3,4,5-Trihydroxy-4-oxo-3,4,4,5-tetrahydrospiro[naphthalene-1(2H),2(3H)-furan]-6-carboxylic acid

C14H14O7 (294.0739)

Cyanthoate

N-(1-Cyano-1-methylethyl)-2-[(diethoxyphosphoryl)sulphanyl]ethanimidic acid

C10H19N2O4PS (294.0803)

Sulfacytine

4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzene-1-sulfonamide

C12H14N4O3S (294.0787)

Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Sulfacytine is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

6-Hydroxymethylsulfadimidine

4-amino-N-[4-(hydroxymethyl)-6-methylpyrimidin-2-yl]benzene-1-sulfonamide

C12H14N4O3S (294.0787)

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

Benzenesulfonamide, 4-amino-N-(5-hydroxy-4,6-dimethyl-2-pyrimidinyl)-

4-amino-N-(5-hydroxy-4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide

C12H14N4O3S (294.0787)

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

Sulfametomidine

4-amino-N-(6-methoxy-2-methylpyrimidin-4-yl)benzene-1-sulfonamide

C12H14N4O3S (294.0787)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1303

ACMC-20n4gr

C13H14N2O6 (294.0852)

(2S,3S)-3-O-caffeyl-2,3,4-trihydroxy-2-methylbutan-1,4-olide|3-O-Caffeoyl-2-C-methyl-D-erythrono-1,4-lactone

C14H14O7 (294.0739)

ACMC-20c8ay

C13H14N2O6 (294.0852)

p-coumaroyl D-malic acid 1-methyl ester

C14H14O7 (294.0739)

Orsellide D

C14H14O7 (294.0739)

{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl trimethysilyl ether

C15H19ClO2Si (294.0843)

3-(6,8-dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid

NCGC00381106-01!3-(6,8-dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid

C14H14O7 (294.0739)

estazolam

C16H11ClN4 (294.0672)

N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants